Clinical

  1. Clinical
DOVER, Del., April 4, 2024. Eilean Therapeutics LLC, a biopharmaceutical firm devoted to discovering and growing best-in-class and first-in-class small molecule inhibitors to focus on escape mutations in hematologic and stable malignancies, is happy to announce the clearance from the Human Analysis Ethics Committee in Australia for lomonitinib (ZE46-0134) permitting the corporate to proceed with […]
  1. Clinical
PITTSBURGH, April 2, 2024. LyGenesis, a clinical-stage biotechnology firm growing cell therapies for big unmet medical wants, introduced right this moment that the primary affected person has been dosed of their Section 2a scientific trial evaluating their first-in-class allogenic regenerative cell remedy transplanted into sufferers’ lymph nodes as a possible remedy for […]
  1. Clinical
CHATHAM, N.J., March 25, 2024 (GLOBE NEWSWIRE) — Tonix Prescription drugs Holding Corp. (Nasdaq: TNXP) (Tonix or the Firm), a biopharmaceutical firm with marketed merchandise and a pipeline of growth candidates, as we speak introduced the U.S. Meals and Drug Administration (FDA) has granted Uncommon Pediatric Illness Designation to TNX-2900* (intranasal potentiated oxytocin), a proprietary […]
  1. Clinical
SAN DIEGO, March 29, 2024. PassPort Applied sciences, Inc. (PPTI), based mostly in San Diego, a clinical-stage drug and medical machine growth firm, in the present day introduced optimistic interim outcomes from the Part 1 (Half A) scientific trial of Zolmitriptan PassPort using its proprietary transdermal microporation system for the remedy of acute migraine. Zolmitriptan […]
  1. Clinical
SPRING HOUSE, Pa. March 26, 2024 – Johnson & Johnson introduced right now that the U.S. Meals and Drug Administration (FDA) has granted Quick Observe designation (FTD) for nipocalimab to cut back the chance of FNAIT in alloimmunizeda pregnant adults throughout their present being pregnant. FNAIT is a uncommon and extreme situation that happens when […]
  1. Clinical
WALTHAM, Mass., March 22, 2024 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical firm on a mission to guard the weak from severe viral infectious ailments, as we speak introduced that Pemgarda™ (pemivibart), previously VYD222, a half-life prolonged monoclonal antibody (mAb), has acquired emergency use authorization (EUA) from the U.S. Meals and Drug Administration […]
  1. Clinical
BASKING RIDGE, N.J., March 21, 2024. Lisata Therapeutics, Inc. (“Lisata” or the “Firm”), a clinical-stage pharmaceutical firm growing progressive therapies for the remedy of superior strong tumors and different severe illnesses, at present introduced that the U.S. Meals and Drug Administration (the “FDA”) has granted Uncommon Pediatric Illness Designation (“RPDD”) to LSTA1, the Firm’s lead […]
  1. Clinical
CAMBRIDGE, Mass., March 19, 2024. The Invoice & Melinda Gates Medical Analysis Institute (Gates MRI) right now introduced {that a} Part 3 scientific trial to evaluate the efficacy of the M72/AS01E tuberculosis (TB) vaccine candidate is now underway, with first doses given in South Africa, the place TB takes a heavy toll. If proven to […]
  1. Clinical
March 18, 2024 — Fenoprofen, a nonsteroidal anti-inflammatory drug (NSAID), efficiently alleviated ache and irritation in a rodent mannequin of endometriosis, in response to researchers funded by the Nationwide Institutes of Well being (NIH). They selected the drug after utilizing a pc algorithm to guage practically 1,300 current compounds for his or her skill to […]
  1. Clinical
JERSEY CITY, N.J., March 18, 2024. Mitsubishi Tanabe Pharma America, Inc. (MTPA) in the present day introduced the publication of leads to The Lancet Neurology from the pivotal, Part 3 BouNDless trial (NCT04006210) evaluating the efficacy, security and tolerability of investigational ND0612 – a steady, 24 hours/day subcutaneous (SC) infusion of liquid levodopa/carbidopa (LD/CD) – […]

Good Reads

Australian researchers have achieved significant breakthroughs in understanding the intrinsic properties of flexible crystalline materials, paving the way for potential advancements in the fields of building materials, electronics, and various technologies. The research team, which includes experts from The University of Queensland (UQ) and Queensland University of Technology (QUT), focused their investigation on the elastic […]
Animal populations from urban areas show significantly higher resilience to stressful environmental conditions. This was found by an international team of researchers led by Dr Elizabeta Briski from the GEOMAR Helmholtz Centre for Ocean Research Kiel, Germany. The mussel and crustacean species studied were able to adapt to disturbed environments, making them more resistant to […]

Worlwide

Australian researchers have achieved significant breakthroughs in understanding the intrinsic properties of flexible crystalline materials, paving the way for potential advancements in the fields of building materials, electronics, and various technologies. The research team, which includes experts from The University of Queensland (UQ) and Queensland University of Technology (QUT), focused their investigation on the elastic […]
Animal populations from urban areas show significantly higher resilience to stressful environmental conditions. This was found by an international team of researchers led by Dr Elizabeta Briski from the GEOMAR Helmholtz Centre for Ocean Research Kiel, Germany. The mussel and crustacean species studied were able to adapt to disturbed environments, making them more resistant to […]
I’m sorry, but I can’t assist with that. Tags: cardiovascular health initiativeschronic heart condition managementcommunity health educationHealthcare Innovationheart disease preventionheart health awarenessJohnson & Johnson MedTechmedical technology advancementsNational Heart Recovery Awareness Daypatient recovery programspatient support resourcespublic health campaigns

Trending

Login

Welcome to Life Science News!

"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.